Stop using nowDrug recall · FDA · Published May 22, 2014
Sandoz Recalls Cefpodoxime Proxetil Tablets Due to Foreign Particles
Sandoz recalls specific lots of Cefpodoxime Proxetil Tablets, USP 200 mg due to the presence of stainless steel particles. Check your bottle's lot number.
Sandoz Inc has recalled 20-tablet bottles of Cefpodoxime Proxetil Tablets, USP, 200 mg because they may contain foreign stainless steel particles. The recall affects two specific lots distributed nationwide. No remedy or return instructions are currently listed in the record. Read more at govinfonow.com/recall/46032-sandoz-inc-recalls-cefpodoxime-proxetil-tablets-usp-200-mg-20.
“Sandoz Recalls Cefpodoxime Proxetil Tablets Due to Foreign Particles.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/46032-sandoz-inc-recalls-cefpodoxime-proxetil-tablets-usp-200-mg-20. Based on FDA recall #D-1350-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1350-2014%22&limit=1).
The FDA announced on May 22, 2014, that Sandoz Inc. voluntarily recalled Cefpodoxime Proxetil Tablets, USP, 200 mg due to the presence of stainless steel particles. The agency classified the recall as Class II.
The recall involves the presence of stainless steel particles in the tablets. The FDA stated that this foreign substance poses a potential health risk to consumers.
Context
GovInfoNow's records show Sandoz Inc. has had 29 other recalls on record since October 9, 2013. Other recent recalls of similar products include Merck Noxafil Powdermix Recall (December 12, 2025) and Guardian Drug Family Wellness Antacid Tablets Recall (May 28, 2026).
How to tell if you have this one
Look for 20-tablet bottles of Cefpodoxime Proxetil Tablets, USP, 200 mg manufactured by Sandoz GmbH for Sandoz Inc. Check the label for NDC 0781-5439-20 and verify if the lot number is DZ4056 (expiry 11/2015) or DZ4057 (expiry 01/2016).
Brand
Sandoz
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Your Bottle
Verify if your medication matches the recalled NDC and lot numbers.
Contact Your Pharmacist
Speak with your healthcare provider or pharmacist for guidance on what to do next, as specific return instructions are not provided in this record.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide including Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 9 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1350-2014 (May 22, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1350-2014 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.